NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Chief Accounting Officer Louise Frederika Kooij sold $3.2M of NewAmsterdam Pharma Company N.V.
Sold$3,185,656
$30.34Price
105,000Shares
−81%Stake
What NAMS did after the filing
- The stock from Thu, Jul 23 open, $30.66
- −17.2%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Sep 4 close.
Traded Mon, Jul 20. Filed Wed, Jul 22, 4:05 PM ET, after the close. Returns use the Jul 23 open and the Sep 4 close. Not investment advice.